Non-invasive Measurement of Hemoglobin Concentration With Pulse Co-oximetry

This study has been completed.
Sponsor:
Information provided by:
University Medical Centre Groningen
ClinicalTrials.gov Identifier:
NCT01060683
First received: February 1, 2010
Last updated: February 28, 2012
Last verified: August 2009

February 1, 2010
February 28, 2012
January 2010
July 2011   (final data collection date for primary outcome measure)
To evaluate the accuracy of continuous SpHb measurement during hepatic resection compared with standard (invasive) Hb measurement [ Time Frame: during operation ] [ Designated as safety issue: No ]
To evaluate the accuracy of continuous SpHb measurement during hepatic resection compared with standard (invasive) Hb measurement [ Designated as safety issue: No ]
Complete list of historical versions of study NCT01060683 on ClinicalTrials.gov Archive Site
the effect of a bolus of crystalloid on SpHb level will be compared to the effect of a bolus of colloid on the SpHb level. [ Time Frame: during operation ] [ Designated as safety issue: No ]
the effect of a bolus of crystalloid on SpHb level will be compared to the effect of a bolus of colloid on the SpHb level. [ Designated as safety issue: No ]
Not Provided
Not Provided
 
Non-invasive Measurement of Hemoglobin Concentration With Pulse Co-oximetry
Liver Resection and Non-invasive Measurement of Hemoglobin Concentration With Pulse Co-oximetry

The purpose of this study is to evaluate the accuracy of continuous SpHb measurement ( Rainbow DCI, Masimo, Irvine Ca, USA) compared to the current method of monitoring (blood sampling), both during phases of hemoconcentration and hemodilution.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:

laboratory hemoglobin, Coagulation variables,blood chemistry,Blood gas analysis

Non-Probability Sample

ASA class I and II patients for elective hepatic resection

Elective Hepatic Resection
  • Biological: Hemoglobin determination + NaCl 0.9% bolus
  • Biological: hemoglobin determination + Venofundin bolus
  • Group 1: 15 patients for elective hepatic resection
    Intervention: Biological: Hemoglobin determination + NaCl 0.9% bolus
  • Group 2: 15 patients for elective hepatic resection
    Intervention: Biological: hemoglobin determination + Venofundin bolus
Vos JJ, Kalmar AF, Struys MM, Wietasch JK, Hendriks HG, Scheeren TW. Comparison of arterial pressure and plethysmographic waveform-based dynamic preload variables in assessing fluid responsiveness and dynamic arterial tone in patients undergoing major hepatic resection. Br J Anaesth. 2013 Jun;110(6):940-6. doi: 10.1093/bja/aes508. Epub 2013 Jan 24.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
30
July 2011
July 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • All patients: Age > 18 years
  • ASA class I and II patient requiring hepatic resection

Exclusion Criteria:

  • Patient refusal
  • Patients with a perioperative blood loss exceeding 5ml/kg
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Netherlands
 
NCT01060683
SpHb-001
No
H.G.D.Hendriks, University Medical Center Groningen
University Medical Centre Groningen
Not Provided
Principal Investigator: Herman G.D. Hendriks, Dr. University Medical Centre Groningen
University Medical Centre Groningen
August 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP